A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy

Molecular subtypes of pancreatic cancer

(2019) Eric A. Collisson et al.   Nature Reviews Gastroenterology & Hepatology

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma

(2019) Farzad Khalvati et al.   Scientific Reports

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

(2018) Sebastian Mueller et al.   NATURE

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

(2018) Francesco Puleo et al.   GASTROENTEROLOGY

Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany

(2017) D. L. Bailey et al.   MOLECULAR IMAGING AND BIOLOGY

CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis

(2017) Armin Eilaghi et al.   BMC MEDICAL IMAGING

Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma

(2017) M. Trajkovic-Arsic et al.   Scientific Reports

Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

(2016) Irina Heid et al.   CLINICAL CANCER RESEARCH

Quantitative imaging to evaluate malignant potential of IPMNs

(2016) Alexander N. Hanania et al.   Oncotarget

Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation

(2015) Bella Kaufman et al.   JOURNAL OF CLINICAL ONCOLOGY

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

(2015) Thibaud P. Coroller et al.   RADIOTHERAPY AND ONCOLOGY

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiomics: the process and the challenges

(2012) Virendra Kumar et al.   MAGNETIC RESONANCE IMAGING

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

(2011) Eric A Collisson et al.   NATURE MEDICINE

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE